Pfizer Inc. and BioNTech SE's mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19
The organization’s new standard test method will support biomedical nanomaterials measurement.
Pierre-Alain Ruffieux was appointed as Lonza’s CEO June after serving as Head of Global Pharma Technical Operations for Roche.
The self-care products supplier is investing $44.7 million to open its new North American headquarters in Michigan.
The Swiss company’s manufacturing capacity for capsules will increase by 15% over the next two years.
A new facility will increase the capacity of ADM-owned microbial technologies supplier Biopolis by five-fold.